Theliatinib

DRUG2 trials

Sponsors

Hutchison Medipharma Limited

Conditions

Cancer

Phase 1

Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor

CompletedNCT02601248

Hutchison Medipharma LimitedCancer

Start: 2012-10-31End: 2016-05-31Updated: 2020-02-13

Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor

TerminatedNCT02601274

Hutchison Medipharma LimitedCancer

Start: 2015-04-30End: 2018-12-31Updated: 2019-02-25